menu

Exploring First-Line Treatment Strategies for Metastatic EGFR-Mutated NSCLC

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Exploring First-Line Treatment Strategies for Metastatic EGFR-Mutated NSCLC

close
Exploring First-Line Treatment Strategies for Metastatic EGFR-Mutated NSCLC
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Charles Turck explores first-line treatment for metastatic EGFR mutated non-small cell lung cancer with pneumonologist Dr. Nicolas Girard, the head of medical oncology at the Institut Curie in Paris.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Dr. Charles Turck explores first-line treatment for metastatic EGFR mutated non-small cell lung cancer with pneumonologist Dr. Nicolas Girard, the head of medical oncology at the Institut Curie in Paris.

Facebook Comments

Programs 6/13/21